Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral stem cell transplantation

Authors:
  • HMHcf Moore
    Hcf Moore
  • CHCl Hardy
    Cl Hardy
  • DPDl Porter
    Dl Porter
  • ELEy Loh
    Ey Loh
  • DVDj Vaughn
    Dj Vaughn
  • SLS Luger
    S Luger
  • SSSj Schuster
    Sj Schuster
  • ESEa Stadtmauer
    Ea Stadtmauer

Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.